article thumbnail

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments

Putting Patients First Blog

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments January 16, 2024 Allen Pinn, Coordinator, Policy The National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2025 Notice of Benefit and Payment Parameters (NBPP) on January 8.

article thumbnail

Considerations for Hernia Patients when Selecting a Surgeon

Putting Patients First Blog

Considerations for Hernia Patients when Selecting a Surgeon January 4, 2024 By: Abdominal Core Health Quality Collaborative Patient Engagement & Advocacy Committee & Abdominal Core Health Quality Collaborative Board of Directors Choosing a surgeon is a decision that can significantly impact patients’ health and well-being.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC Comments on Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies

Putting Patients First Blog

Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.

article thumbnail

NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents

Putting Patients First Blog

The NHC commends CMS for its work in making these materials understandable – a vital component of beneficiary communication and education. While we find these documents generally well-constructed and accessible, there are opportunities for improvement to ensure they fully convey the MPPP’s intricacies to all beneficiaries.

article thumbnail

NHC Comments on Draft CY 2025 Part D Redesign Program Instructions

Putting Patients First Blog

Ensure Comprehensive Transparency in Formulary Management: Provide clear, comprehensive guidelines to Part D plans to ensure transparency in plan coverage, tiering, and utilization management (UM) policies, offering safeguards against practices that could restrict access to necessary treatments.

article thumbnail

Clinical trials for rare diseases

European Pharmaceutical Review

FDA is expected to provide initial feedback on the data submitted by July 2024, with further data to be collected and analysed over the next two years. When Aidan’s insurance company denied coverage for EXONDYS, the data she captured overturned the denial in 24 hours without engaging in the appeal process.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.